Contract notice
Section I: Contracting
authority
I.1) Name and addresses
NHS South West — Acutes
1234
Acute Trusts
Torquay
South west region
UK
Contact person: Louise Rowe
Telephone: +44 1803660069
E-mail: louise.rowe3@nhs.net
NUTS: UKK42
Internet address(es)
Main address: http://www.torbaypharmaceuticals.nhs.uk/
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=24107&B=NHSSW
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=24107&B=NHSSW
Tenders or requests to participate must be sent to the abovementioned address
I.4) Type of the contracting authority
Regional or local authority
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Contract Sales Team
II.1.2) Main CPV code
79900000
II.1.3) Type of contract
Services
II.1.4) Short description
Torbay Pharmaceuticals have been manufacturing pharmaceuticals for over 35 years and is wholly owned by Torbay and South Devon NHS Foundation Trust. They are currently the largest NHS pharmaceutical manufacturing unit in the UK, manufacturing a range unlicensed and licensed terminally sterilised injectables, and CE Marked Medical Devices across a range of therapeutic areas. Annual Turnover is circa 20 000 000 GBP pa and all profits are returned to the NHS Trust. The relocation and amalgamation of all sites to a single new purpose-built state-of-the-art facility is now complete: with this move, Torbay Pharmaceuticals will be positioned to continue to meet the market demand, capitalise on business partnerships and opportunities, whilst supporting the NHS and other customers. Following a comprehensive strategic review the strategy for the organisation has been defined and agreed implementation will commence early 2018.
II.1.5) Estimated total value
Value excluding VAT:
600 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.2) Additional CPV code(s)
79990000
II.2.3) Place of performance
NUTS code:
UKK42
UKK4
UKK
UK
II.2.4) Description of the procurement
Torbay Pharmaceuticals have been manufacturing pharmaceuticals for over 35 years and is wholly owned by Torbay and South Devon NHS Foundation Trust. They are currently the largest NHS pharmaceutical manufacturing unit in the UK, manufacturing a range unlicensed and licensed terminally sterilised injectables, and CE Marked Medical Devices across a range of therapeutic areas. Annual Turnover is circa 20 000 000 GBP pa and all profits are returned to the NHS Trust. The relocation and amalgamation of all sites to a single new purpose-built state-of-the-art facility is now complete: with this move, Torbay Pharmaceuticals will be positioned to continue to meet the market demand, capitalise on business partnerships and opportunities, whilst supporting the NHS and other customers. Following a comprehensive strategic review the strategy for the organisation has been defined and agreed implementation will commence early 2018.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
600 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 36
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
III.2) Conditions related to the contract
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.6) Information about electronic auction
An electronic auction will be used
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
30/05/2018
Local time: 12:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Tender must be valid until:
29/06/2018
IV.2.7) Conditions for opening of tenders
Date:
30/05/2018
Local time: 12:00
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.4) Procedures for review
VI.4.1) Review body
VI.4.2) Body responsible for mediation procedures
VI.4.4) Service from which information about the review procedure may be obtained
VI.5) Date of dispatch of this notice
01/05/2018